GlaxoSmithKline Heads 2007 Most Ethical Pharmas List
-
Font Size:
Geneva-based Covalence is publishing Wednesday its third annual ethical reputation ranking, giving the best ranked companies as well as those companies which have made the most progress in 2007.
Below are those companies with the best ethical scores in the Pharmaceutical and Biotechnology sector.
Best EthicalQuote Score and Best EthicalQuote Progress are given by confronting positive and negative news. Best Reported Performance is calculated by quantifying positive news only – it shows how companies report on their ethical performance without considering criticisms and demands. Some companies being highly targeted by activists have a low EthicalQuote Score while at the same time ranking high in terms of Reported Performance. We can assume that “ethical demands” (negative news i.e. stakeholder issues, campaigns, expectations) stimulate “ethical offers” (positive news i.e. initiatives, reporting, communication by companies).
You can view and download the full report here (includes all sectors).
Best EthicalQuote Score
1.GlaxoSmithKline (GSK)
2.Johnson & Johnson (JNJ)
3.Bristol Myers Squibb (BMS)
4.Abbott (ABT)
5.Novartis (NVS)
6.Roche (RHHBY.PK)
7.Boehringer Ingelheim
8.Astra Zeneca (AZN)
9.Pfizer (PFE)
10.Sanofi Aventis (SNY)
Best EthicalQuote Progress
1.GlaxoSmithKline
2.Abbott
3.Johnson & Johnson
4.Sanofi Aventis
5.Boehringer Ingelheim
6.Schering Plough (SGP)
7.Takeda (TKPHF.PK)
8.Astra Zeneca
9.Bristol Myers Squibb
10.Amgen (AMGN)
Best Reported Performance
1.GlaxoSmithKline
2.Abbott
3.Novartis
4.Wyeth (WYE)
5.Merck & Co Inc (MRK)
6.Pfizer
7.Johnson & Johnson
8.Eli Lilly (LLY)
9.Sanofi Aventis
10.Astra Zeneca
- Myriad Genetics, Inc. F4Q08 (Qtr End 06/30/08) Earnings Call Transcript »
- American Oriental Bioengineering, Inc. Q2 2008 Earnings Call Transcript »
- Would Genentech Be Better Off Left Alone by Roche? »
- Biotech ETFs: Can You Handle 209% Volatility? »
- AstraZeneca Gives FluMist Spray a Shot in the Arm »
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
ETFs In Focus
-
Editor's Picks
-
Most Popular
- Railway Stocks Haul Transportation ETF to Solid Returns
- Protect Your Portfolio: Here Comes the Squeeze
- The Most Important Price in an Economy
- Income Planning and Safe Withdrawal Rates
- Solvency and Liquidity: Non-Identical Twins
- The Great Inflation Debate
- Full list of Editor's Picks »
- The Disconnect Between Supply and Demand in Gold & Silver Markets »
- The Great Consumer Crash of 2009 »
- Cramer Continues to Dig a Sirius Hole for Himself »
- Petrobras: Buy and Sit Tight Like Soros »
- Apple: Great Company with Lofty Valuation - Due for Pullback »
- Interview with Jim Rogers, Part I: Bigger Financial Shocks Loom »
- Jim Cramer's Unnecessary Beating Over Sirius »
- Wall Street Breakfast: Must-Know News »
- 5 Impressive Stocks in This Difficult Market »
- Wall Street Breakfast: Must-Know News »
- Forget $100 a Barrel - Oil Will Plummet to $30 »
-
Long Ideas
-
Short Ideas
-
Cramer's Picks
- Why I'm Buying Amylin Now
- HP: Good To Grow
- Screener Picks: Three Mega-cap Long Picks
- Financial Downgrades Down Markets - Fast Money Recap (8/19/08)
- Transocean: Drilling Deep for Profits
- Whose Freddie Investment Thesis Is Right?
- Steel Dynamics: Bullish with a Share Repurchase Program
- E-Trade Financial Carries High Risk-Reward
- Interested in Bank of America? Consider the Preferred Shares
- Northgate: Mid-Tier Gold Producer with Strong Cashflow
- Full list of Long Ideas »
- Salesforce.com: It's All About the Guidance
- Three Casino Stocks Rolling Over
- New Web Site For Short Sellers: You Gotta Love Capitalism
- Commodity Carnage: Where to Turn Next?
- Fannie and Freddie Shareholders Run for the Exit
- Goldman: Readying Short Position Initiation Sequence
- Apple: Great Company with Lofty Valuation - Due for Pullback
- Russia's Too Risky - Barron's
- Fannie, Freddie Shareholders Will Be Left Holding the Bag - Barron's
- Pilgrim's Pride: The Weakest Link in the Food Chain
- Full list of Short Ideas »
- Real Buys - Cramer's Mad Midday (8/20/08)
- Coke vs. Pepsi - Cramer's Mad Money (8/19/08)
- Clean Energy - Cramer's Lightning Round (8/19/08)
- Still Growing - Cramer's Mad Midday (8/19/08)
- Which Stock to Pick - Cramer's Mad Money (8/18/08)
- Buy Weyerhauser - Cramer's Lightning Round (8/18/08)
- The Price of Oil - Cramer's Mad Money (8/18/08)
- Great Execution Pick - Cramer's Mad Money (8/14/08)
- Beaten Down Buy - Cramer's Lightning Round (8/14/08)
- The Fry Guy - Cramer's Midday Mad Money (8/14/08)
- Full list of Cramers Picks »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »



This article has 1 comment:
Lets just simplify this. If being ethical was a way to make lots of money like selling drugs is.. then they would be in the ethics business and that is all they would sell. red ethics..and blue ethics and you would have to make a choice on which one to swallow.
Let us hope that someone..someday might really become ethical.